Studies related to Insomnia and Melatonin

Prolonged-release Melatonin Improves Sleep Quality And Morning Alertness In Insomnia Patients Aged 55 Years And Older And Has No Withdrawal Effects

Effect Decrease
Trial Design Double blind
Trial Length n/a
Number of Subjects 170
Sex n/a
Notes for this study:
In primary insomnia patients, 2mg of prolonged release melatonin was effective in reducing sleep latency (time to sleep) and improving sleep quality without withdrawal effects.

Full details on all 4 studies are available to Examine members — try free for 7 days.

Already a member? Log in now to access.

Supplements

Articles

Health Topics

NERD

Personalized

Protein Intake Guide

About

Never miss an update!

Your e-mail is safe with us. We don’t share personal data.

This website is certified by Health On the Net Foundation. Click to verify.